Maulik Nanavaty

Maulik Nanavaty is currently serving as the Chief Executive Officer at Anumana, an AI-driven health technology company focused on enhancing cardiac care. In addition to this role, Maulik holds the position of President, Ventures at nference. Since January 2016, Maulik has been a Board Member at Rani Therapeutics. Previous experience includes a significant tenure at Boston Scientific from January 2005 to October 2023, where roles included SVP and President of Neuromodulation, and previously VP of Corporate Strategy in Japan. Maulik's career began at Baxter International Inc., where various executive positions were held from January 1990 to December 2005. Educational credentials include an MBA from The University of Chicago Booth School of Business and a PhD in Pharmaceutical Sciences from the University of Illinois Chicago.